Your Bones: How You Can Prevent Osteoporosis and Have Strong Bones for Life_Naturally
Format: PDF / Kindle (mobi) / ePub
Your Bones contains everything you need to know for healthy bones in one book, providing scientifically based advice which highlights natural prevention and treatment strategies. This UPDATED AND EXPANDED edition includes many new studies on the dangers of the bisphosphonate drugs and an in depth discussion of two new drugs with potential adverse effects. Also new: more information on bone-busting patent medicines, calcium supplementation options, strontium, vitamin K2, and zinc as well as a section on bone-building exercise.
of Westminster, LondonEditor-in-Chief, Journal of Bodywork & Movement Therapies “This is one of the best books ever written on bone health—absolutely fantastic! In this book, Lara Pizzorno, MA provides scientifically based advice for men and women of all ages to help them develop and maintain strong healthy bones. She makes a complex issue easily comprehensible and provides information that empowers the reader to take measures towards ensuring their own bone health. I highly recommend it.”
osteoporosis. Int J Oral Maxillofac Implants Jan-Feb;22(1):146–53. PMID: 17340909. Lee, J. 2009. Complication related to bisphosphonate therapy: osteonecrosis of the jaw. J Infus Nurs Nov-Dec;32(6):330–5. PMID: 19918142. Lo, J. C., F. S. O’Ryan, N. P. Gordon, et al. 2010. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg Feb;68(2):243–53. PMID: 19772941. Longo, R., M. A. Castellana, and G. Gasparini. 2009. Bisphosphonate-related
Spine Mar;72(2):124–8. PMID: 15797491. Hall, S. L. and G. A. Greendale. 1998. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int Sep;63(3):183–9. PMID: 9701620. 84. Sahni, S., M. T. Hannan, D. Gagnon, et al. 2009. Protective effect of total and supplemental vitamin C intake on the risk of hip fracture—a 17-year follow-up from the Framingham Osteoporosis Study. Osteoporos Int Nov;20(11):1853–61. PMID: 19347239. 85.
found that low-energy thighbone fractures (i.e., fractures occurring during normal daily activities) with a specific, uncommon transverse (crosswise) pattern were associated with Fosamax® use. This is especially concerning since the thighbone is the thickest, strongest bone in the body. Seventy patients with this type of low-energy thighbone fracture (59 women, 11 men, average age 74.7 years) were identified. Of these, 25 were taking Fosamax®, and 19 of them suffered a low-energy thighbone
bisphosphonates to their regional hospital for low-energy thighbone fractures. Some of these patients had been on Fosamax® for as little as 16 months; one had been on Boniva® only 4 months.40 Numerous papers are now reporting that bisphosphonates’ repression of bone turnover actually promotes the accumulation of microcracks and the occurrence of unexpected stress fractures, characteristically at the subtrochanter of the femur (below the trochanter but in the upper part of the body of the thigh